Amanote Research
Register
Sign In
Use of Lipid Lowering Drugs in Primary Care Is Highly Variable
BMJ
doi 10.1136/bmj.317.7166.0e
Full Text
Open PDF
Abstract
Available in
full text
Date
October 24, 1998
Authors
Unknown
Publisher
BMJ
Related search
Use of Antiepileptic Drugs and Lipid-Lowering Agents in the United States
Epilepsy and Behavior
Neurology
Behavioral Neuroscience
Lipid-Lowering Drugs (Statins) and Peripheral Neuropathy
Electronic Physician
Prescription Patterns of Lipid-Lowering Agents in the Community–Analysis of Primary Care Data
Advances in Pharmacoepidemiology & Drug Safety
Adherence to Lipid Lowering Drugs in Patients With Schizophrenia
Clinical Therapeutics
Pharmacology
Lipid Lowering for Primary Prevention of Stroke in Older Adults?
British Medical Journal
Medicine
Use of Lipid-Lowering Drugs in Older Adults With and Without Dementia: A Community-Based Epidemiological Study
Journal of the American Geriatrics Society
Gerontology
Geriatrics
Lipid Lowering Drugs and Inflammatory Changes: An Impact on Cardiovascular Outcomes?
Annals of Medicine
Medicine
Role of Pharmacogenetics in the Use of CNS Drugs: From Drug Pipeline to Primary Care?
Expert Review of Neurotherapeutics
Neuroscience
Neurology
Pharmacology
Socioeconomic and Ethnic Differences in Use of Lipid-Lowering Drugs After Deregulation of Simvastatin in the UK: The Whitehall II Prospective Cohort Study
Atherosclerosis
Cardiovascular Medicine
Cardiology
